Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
Getinge has a strong market share in India within several product segments
Women of all ages will get round-the-clock access to comprehensive treatment
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
Ryzneuta is a novel dimeric G- CSF long-acting fusion protein without pegylation. The Biologics License Application (BLA) of Ryzneuta is currently under late-stage review by the US FDA for Chemotherapy-Induced Neutropenia (CIN)
R&D center would be doing a lot of new product generation projects, process optimization, scale-up and product life cycle management work, full synthetic labs, the kilo labs, the process safety labs, and the population lab
In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers
3D CMOS chip for connecting electroactive tissues and organoids to software
Subscribe To Our Newsletter & Stay Updated
